Diane Descamps
University of Paris
372 Papers
2.9K Citations
Diane Descamps is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Viral load. The author has an hindex of 45, co-authored 311 publications. Previous affiliations of Diane Descamps include Claude Bernard University Lyon 1 & French Institute of Health and Medical Research.
Chat about Author
Papers
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
Elisa Gentilotti,Anna Górska,Adriana Tami,Roy Gusinow,Massimo Mirandola,J Rodríguez Baño,Zaira R. Palacios Baena,Elisa Rossi,Jan Hasenauer,Iris Lopes-Rafegas,Elda Righi,Natascia Caroccia,Salvatore Cataudella,Zeno Pasquini,Thomas Osmo,Lidia Del Piccolo,Alessia Savoldi,Samir Kumar Singh,Fulvia Mazzaferri,Maria Giulia Caponcello,Gerolf C de Boer,Gabriel Levy Hara,Pasquale De Nardo,S.K. Malhotra,Lorenzo Maria Canziani,Jade Ghosn,Aline-Marie Florence,Nadhem Lafhej,Bernardina T. F. van der Gun,Maddalena Giannella,Cédric Laouénan,Evelina Tacconelli,Mariana Nunes Pinho Guedes,Gaia Maccarrone,M. Diletta Pezzani,Marcella Sibani,Ruth Davies,Stefania Vitali,G. Franchina,G. Tomassini,Concetta Sciammarella,Riccardo Cecchetto,Davide Gibellini,Chiara Konishi De Toffoli,Giulia Rosini,C. Perlini,Marco Meroi,Filippo Cioli Puviani,Daniele Fasan,Claudio Micheletto,Stefania Montemezzi,Nicolò Cardobi,Gianluca Vantini,Gloria Mazzali,Giovanni Stabile,Maddalena Marcanti,Marco Pattaro Zonta,Deborah Calì,Anna E. Mason,Cinzia Perlini,Paolo Gisondi,M. Mongardi,S. Sorbello,Karin I Wold,Maria F. Vincenti-Gonzalez,Alida Veloo,Valerie P R Harmsma,Daniele Pantano,M. van der Meer,Lilli Gard,E. Lizarazo,Marjolein Knoester,A. Friedrich,Hubert G. M. Niesters,Pierluigi Viale,Domenico Marzolla,Federica Cosentino,Michela Di Chiara,Giacomo Fornaro,Cecilia Bonazzetti,Beatrice Tazza,Alice Toschi,Oana Vetamanu,M. E. Giacomini,Fabio Filippo Trapani,Lorenzo Marconi,Luciano Attard,Sara K. Tedeschi,Liliana Gabrielli,Tiziana Lazzarotto,Paulina Olivares,J. Castilla,Javier Vélez,Virginia Almadana,Lucía Martín-Barrera,Ana Belén Martín-Gutiérrez,David Gutiérrez-Campos,Marta Fernández-Regaña,Ana Silva-Campos,Patricia Fernández-Riejos,Maria Isabel García-Sánchez,Carla Valeria Giuliano,C. López,Gabriela Neumann,J. Camporro,Lautaro De Vedia,Hugo Agugliaro,Gabriella Scipione,Chiara Dellacasa,Balasubramanian Chandramouli,S. Gioiosa,Juan M. Naranjo,Maurizio Ortali,Angelina Konnova,Akshita Gupta,Mathias Smet,An Hotterbeekx,M. Berkell,Elisa Sicuri,Delphine Bachelet,Lila Bouadma,Minerva Cervantes-Gonzalez,Anissa Chair,Charlotte Charpentier,Leo Bertrand Chenard,Diane Descamps,Ha Doan,Xavier Duval,Marina Esposito-Farèse,Isabelle Hoffmann,Ouifiya Kafif,Quentin Le Hingrat,Sophie Letrou,F. Mentré,Marion Schneider,Coralie Tardivon,Jean-François Timsit,Sarah Tubiana,Amal Abrous,Sandrine Couffin-Cadiergues,F. D. da Silva,Helene Esperou,Ikram Houas,S. Jaafoura,Aurélie Papadopoulos,Séverine Ansart,Adrien Auvet,Firouzé Bani-Sadr,Louis Arthur Bernard,F. Bissuel,Elisabeth Botelho-Nevers,Damien Bouhour,André Cabié,P. Caraux Paz,Christian Chidiac,Catherine Chirouze,Tomasz Chroboczek,H Cordel,R. Courtois,Nathalie De Castro,Sylvain Diamamntis,Jean-Luc Diehl,Félix Djossou,Céline Dorival,Olivier Epaulard,Valerie Gaborieau,François Goehringer,M. Gousseff,Simon Jamard,Cédric Joseph,Karine Lacombe,Soizic Le Mestre,Vincent Le Moing,Jean-Daniel Lelièvre,Olivier Lesens,Moïse Machado,Mylène Maillet,Victoria Manda,Guillaume Martin-Blondel,Martin Martinot,Vanina Meysonnier,Jean-Michel Molina,Eric Oziol,Vincent Pestre,Lionel Piroth,Julien Poissy,Christian Rabaud,François Raffi,Blandine Rammaert,Christophe Rapp,Stanislas Rebaudet,Pierre-Marie Roger,D. Roux,Eric Senneville,Pierre Tattevin,Aurélie Wiedemann,David Zucman +196 more
TL;DR: New evidence is provided suggesting that PCS can be classified by clinical phenotypes with different impact on QoL, underlying possible different pathogenic mechanisms, as well as identifying factors associated to each clinical phenotype and to severe PCS.
49
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection.
Benoit Visseaux,Benoit Visseaux,Quentin Le Hingrat,Gilles Collin,Valentine Marie Ferré,Alexandre Storto,Houria Ichou,Donia Bouzid,Nora Poey,Etienne de Montmollin,Diane Descamps,Nadhira Houhou-Fidouh +11 more
TL;DR: The RealStar® SARS-CoV-2 RT-PCR Kit Researh Use Only (Altona) provides a robust option for all molecular biology laboratories, with a strong real-life LoD and is compatible with various real-time PCR platforms.
46
Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naïve Patients Infected with Non-B HIV-1 Subtypes
Almoustapha Issiaka Maiga,Almoustapha Issiaka Maiga,Diane Descamps,Laurence Morand-Joubert,Isabelle Malet,Anne Derache,Mamadou Cisse,Victoria Koita,Alain Akonde,Bah Diarra,Marc Wirden,Anatole Tounkara,Yvan Verlinden,Christine Katlama,Dominique Costagliola,Bernard Masquelier,Vincent Calvez,Anne-Geneviève Marcelin +17 more
TL;DR: Although the prevalence of ETR RAMs in treatment-naïve patients infected with non-B HIV-1 subtypes was 10%, in most cases this had no significant impact on ETR susceptibility, however, the transmission of drug-resistant viruses with Y181C in a non- B genetic background has a potential for impact onETR susceptibility.
Comparative Selection of the K65R and M184V/I Mutations in Human Immunodeficiency Virus Type 1-Infected Patients Enrolled in a Trial of First-Line Triple-Nucleoside Analog Therapy (Tonus IMEA 021)
Christophe Delaunay,Françoise Brun-Vézinet,Roland Landman,Gilles Collin,Gilles Peytavin,Aldo Trylesinski,Philippe Flandre,Michael W. Miller,Diane Descamps +8 more
TL;DR: A convergent genetic pathway to resistance, associated with lower antiretroviral potency, may explain the high selection rate of these mutations in this trial.
46
Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients.
Antoine Bénard,Florence Damond,Pauline Campa,Gilles Peytavin,Diane Descamps,Caroline Lascoux-Combes,Audrey Taieb,François Simon,Brigitte Autran,Françoise Brun-Vézinet,Geneviève Chêne,Sophie Matheron +11 more
TL;DR: Sustained elevation of CD4 cell count in the first 2 years of combination antiretroviral therapy shows the potential for lopinavir/ritonavir regimens as first-line therapy in HIV-2 infection.
46